Sub-Saharan Africa accounts for 43% of global neonatal deaths, yet neonatal tria...
Africa Trials
1,252
US Trials
10,923
Gap Ratio
9x
Gini
0.732
Key Finding
Africa hosted 1,252 neonatal trials versus 10,923 in the United States, a 9-fold disparity in research investment.
Regional Comparison
Distribution Analysis
Inequality Profile
Temporal & Structural
Why It Matters
Sub-Saharan Africa accounts for 43% of global neonatal deaths, yet neonatal trial investment is a fraction of what's needed to test context-appropriate interventions for low-resource settings.
The Evidence 133 words · target 156
In the burden-versus-investment landscape of African health research, does the distribution of neonatal trials across African nations reveal a systematic research gap? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the rate ratio comparing Africa to other regions as the primary estimand using registry metadata for each nation. Africa hosted 1,252 neonatal trials (5.2% of its portfolio) compared to 10,923 in the United States, yielding a 0.0-fold disparity in per-population investment. Sensitivity analysis using Gini coefficient (0.732) confirmed the inequality finding and bootstrap resampling showed stable estimates. These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa. Interpretation is constrained by missing sub-national data and the exclusion of observational studies from the analysis.
Sentence Structure
Question
In the burden-versus-investment landscape of African health research, does the distribution of neonatal trials across African nations reveal a systematic research gap?
Dataset
This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.
Method
gov through April 2026.
Primary Result
Investigators computed the rate ratio comparing Africa to other regions as the primary estimand using registry metadata for each nation.
Robustness
Africa hosted 1,252 neonatal trials (5.
Interpretation
2% of its portfolio) compared to 10,923 in the United States, yielding a 0.
Boundary
0-fold disparity in per-population investment.
Extra
Sensitivity analysis using Gini coefficient (0.
Extra
732) confirmed the inequality finding and bootstrap resampling showed stable estimates.
Extra
These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa.
Extra
Interpretation is constrained by missing sub-national data and the exclusion of observational studies from the analysis.